Why is Bladder Cancer Awareness Month important?
Bladder cancer is more common than many realise. Every year, over 610,000 people are diagnosed with bladder cancer around the world, and more than 1.9 million people are living with and beyond bladder cancer. Bladder cancer is the 9th most commonly diagnosed cancer and the 13th cause of death from cancer globally. Yet, for many patients who receive this diagnosis, it is the very first time that they learn of bladder cancer or its symptoms.
In May, let’s spark conversations that raise awareness about bladder cancer by highlighting the symptoms of bladder cancer and overcoming any barriers to seeking medical advice.
This year we will once again say it out loud: Feeling unsure? Get checked.
How can you get involved?
There are a number of different ways that you can join the community and lend your support this Bladder Cancer Awareness Month.
Our secretariat team and several WBCPC Board Members attended the European Association of Urology 2024 (EAU24) Congress in Paris, France which took place during 5-8 April. During this event, we hosted a booth where we invited urologists, allied healthcare professionals, patients and others in attendance to learn more about the World Bladder Cancer Patient Coalition and our member organisations.
During the congress, we had the opportunity to talk with visitors from different countries about the results of our Global Bladder Cancer Patient &
The second video in our five-part series “5 Women, 5 Experiences” , introduces the inspiring positivity of Ana María. Aged 79 and living in Buenos Aires, Argentina Ana María shares her bladder cancer journey.Diagnosed with bladder cancer in 2022, her cancer experience was not her first one, as she overcame breast cancer few decades before.
Ana María is part of a new research study, or clinical trial, investigating new treatment options for muscle-invasive bladder cancer.
World Health Day 2024, under the theme ‘My Health, My Right,’ highlights the necessity of universal access to health services, crucial for addressing diseases like bladder cancer – a disease diagnosed in over 610,000 people worldwide each year.
Bladder cancer does not discriminate, affecting individuals across all demographics. However, its impact can be more severe in communities where access to quality healthcare is limited. Early detection and treatment of bladder cancer can significantly improve outcomes,
WBCPC President, Dr Lydia Makaroff, presented on the use of digital technology and data-driven shared decision-making at the European Association of Urology 2024 (EAU24), Europe’s largest Annual Urology Congress, in Paris, France this week.
Her presentation focused on how new technologies and AI, in particular, are reshaping the way patients and doctors work together to make health decisions. During her presentation, she discussed the impact of digital tools on patients through 3 case studies:
World Bladder Cancer Awareness Month 2024 (BCAM24) is around the corner, and we are thrilled to share with you this year’s Campaign Toolkit.
This May, we are building on the success of “Feeling Unsure? Get Checked” campaign we launched last year. During Bladder Cancer Awareness Month, we aim to foster engagement and share the important message that drives awareness around speaking to a healthcare professional as soon as possible when spotting blood in the urine,
The World Bladder Cancer Patient Coalition warmly welcomes two patients with lived bladder cancer experience to the Board of Directors. Sarah Coffey Dégrange and Helen Lacy, both passionate and committed advocates in their respective countries, join the Board to serve a 3-year term from 2024 to 2027.
Sarah Coffey Dégrange, Irish and living in France, a survivor of bladder cancer, and a passionate patient advocate with WBCPC member organisation Cancer Vessie France. Following her diagnosis and successful treatment,
The recently published OECD report, titled “Beating Cancer Inequalities in the EU – spotlight on cancer prevention and early detection” marks a significant step towards addressing the disparities in cancer care and outcomes. This report emphasises the critical need for comprehensive prevention and early cancer detection strategies, highlighting the importance of public education, lifestyle modifications, and equitable access to healthcare services.
Our own WBCPC Global Bladder Cancer Patient &
ASCO Genitourinary Cancer Symposium is the leading annual meeting organised by the American Society of Clinical Oncology on January 25-27, 2024. It focuses on genitourinary cancers and scientific research in this field. We have selected four bladder cancer research studies presented at ASCO GU, with lay summaries of each study provided below.
This year, World Bladder Cancer Patient Coalition (WBCPC) also marked a significant achievement by presenting the Global Bladder Cancer Patient &
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
